Technology area: Semiconductors, Circuits & Optics
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Silverpeutics Inc. holds a patent portfolio in the Semiconductors, Circuits & Optics technology area. The company is currently addressing 1 pending office action. This figure represents the total volume of active prosecution for the company at this time.
The portfolio's active matters are managed by 1 distinct examiner. This examiner is situated within 1 distinct art unit. Such a concentrated structure indicates that the current patent office interaction is limited to a single technical group and a single individual within the semiconductor sector.
XING, CHRISTINA ILONA is the busiest examiner for this portfolio, holding 1 busiest examiner pending office action. This 1 action accounts for the entirety of the 1 pending office action reported for the company. The prosecution strategy is therefore focused on the specific requirements and feedback of this one examiner.
With 1 distinct examiner and 1 distinct art unit, there is no diversity in the current review process. Practitioners should focus on the specific patterns of the art unit where the pending office action is being evaluated.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| XING, CHRISTINA ILONA | 1 | 83.0% | +10.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19203667 | Optical Device for Monitoring the Silver Content of Thin Films | XING, CHRISTINA ILONA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19203667 | Optical Device for Monitoring the Silver Content of Thin Films | XING, CHRISTINA ILONA | — |
| Art Unit | Apps |
|---|---|
| 2877 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19203667 | Optical Device for Monitoring the Silver Content of Thin Films | XING, CHRISTINA ILONA | 2877 | §103§112 | Non-Final OA | — | Pending | May 09, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSilverpeutics Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Christina Ilona Xing has the most, with 1 of Silverpeutics Inc.'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.
